Pellegrino Musto

50PUBLICATIONS
207CO-AUTHORS
Medical mycologyHaematologyOrthopticsMedical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 14, 2026
Effects of immunosuppressive and biological drugs in patients with asymptomatic monoclonal gammopathies (MGUS or smoldering myeloma) and concomitant autoimmune disorders: Results from the real-life MUSA study.

|Jun 23, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

|Jun 08, 2026
Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

|Jun 08, 2026
How unfitness criteria can make a difference in treating AML patients with hypomethylating agents and venetoclax.

|May 20, 2026
One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms.

|Feb 12, 2026
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study.

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo

Pageof 9

Frequent Collaborators

14 joint publications

Francesco Albano

10 joint publications

Francesca Gay

7 joint publications

Francesco Tarantini

7 joint publications

Giuseppe Ingravallo